David R Snydman
Overview
Explore the profile of David R Snydman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
2940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Blumberg E, Collins G, Young J, Nguyen M, Michonneau D, Temesgen Z, et al.
Transpl Infect Dis
. 2021 Nov;
24(1):e13770.
PMID: 34821423
Background: Clostridioides difficile infection (CDI) is a significant cause of morbidity and mortality in recipients of solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). In retrospective single center...
22.
Perry W, Chow J, Snydman D
Clin Transplant
. 2021 Jul;
35(9):e14412.
PMID: 34245177
The impact of sex on immune composition in the setting of solid organ transplantation is unknown. Immunocompetent men and women have quantitative differences in multiple markers of immunity, including lymphocyte...
23.
Chow J, Ruthazer R, Boucher H, Vest A, DeNofrio D, Snydman D
Transpl Infect Dis
. 2021 May;
23(4):e13634.
PMID: 33982834
Background: Neutropenia is a serious complication following heart transplantation (OHT); however, risk factors for its development and its association with outcomes is not well described. We sought to study the...
24.
Perry W, Paulus J, Price L, Snydman D, Chow J
Clin Infect Dis
. 2020 Dec;
73(11):e3797-e3803.
PMID: 33279963
Background: Cell-mediated immunity is a specific target of several medications used to prevent or treat rejection in orthotopic heart transplantation. Low absolute lymphocyte count (ALC) has potential to be a...
25.
Raval A, Kistler K, Tang Y, Murata Y, Snydman D
Transplant Rev (Orlando)
. 2020 Nov;
35(1):100587.
PMID: 33190040
Various CMV anti-viral (AV) preventive strategies have been utilized in KTRs. We examined efficacy, safety and costs of CMV-AV prevention strategies in KTRs using a systematic literature review (SLR) of...
26.
Raval A, Kistler K, Tang Y, Murata Y, Snydman D
Transpl Infect Dis
. 2020 Oct;
23(2):e13483.
PMID: 33012092
Kidney transplant recipients (KTRs) have increased risk for cytomegalovirus (CMV) infection/disease given the necessity of drug-induced immunosuppression. A comprehensive review of published literature reporting real-world data on prevention strategies utilized...
27.
Qian X, Yanagi K, Kane A, Alden N, Lei M, Snydman D, et al.
Am J Physiol Gastrointest Liver Physiol
. 2020 Jun;
319(2):G227-G237.
PMID: 32597706
Antibiotic treatment is a standard therapy for infection, but dysbiosis of the gut microbiota due to antibiotic exposure is also a major risk factor for the disease. Following an initial...
28.
Gardiner B, Chow J, Brilleman S, Peleg A, Snydman D
Transpl Infect Dis
. 2019 Oct;
21(6):e13189.
PMID: 31581352
Background: Cytomegalovirus (CMV) remains a significant contributor to morbidity and mortality following solid organ transplantation (SOT). While recurrent infection occurs in up to 30% of patients, its impact on mortality...
29.
Poutsiaka D, Porto M, Perry W, Hudcova J, Tybor D, Hadley S, et al.
Open Forum Infect Dis
. 2019 Jul;
6(7):ofz271.
PMID: 31281865
Background: Sepsis definitions have evolved, but there is a lack of consensus over adoption of the most recent definition, Sepsis-3. We sought to compare Sepsis-2 and Sepsis-3 in the classification...
30.
Tickoo M, Ruthazer R, Bardia A, Doron S, Andujar-Vazquez G, Gardiner B, et al.
BMC Pulm Med
. 2019 Jul;
19(1):118.
PMID: 31262278
Background: Despite well-defined criteria for use of antibiotics in patients presenting with mild to moderate Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD), their overuse is widespread. We hypothesized that...